ECE2016 Eposter Presentations Adrenal cortex (to include Cushing's) (85 abstracts)
1Tokai University School of Medicine, Isehara-shi, Kanagawa-ken, Japan; 2Seirei Numazu Hospital, Numazu-shi, Shizuoka-ken, Japan.
We report three cases of Cushings syndrome (CS) with bilateral adrenal tumors. When bilateral adrenal tumors are encountered, the differential diagnosis is difficult, especially in the functioning bilateral adrenocortical adenoma. Adrenal scintigraphy has become a standard technique to determine the laterality of excessive hormone secretion; however, this examination results in bilateral adrenal activity in the functioning bilateral adrenocortical adenoma. Our three patients were diagnosed with adrenocorticotropic hormone (ACTH)-independent CS based on biochemical testing, and an abdominal computed tomography (CT) scan detected bilateral adrenal tumors. Adrenal scintigraphy, which has become a standard technique to determine the laterality of excessive hormone secretion, showed bilateral adrenal activity in all cases. However, adrenal venous sampling (AVS) demonstrated three different hormone-excess patterns (case 1: bilateral cortisol-excess secretions; case 2: unilateral cortisol-excess secretion and bilateral aldosterone-excess secretions; and case 3: bilateral cortisol-excess secretions and bilateral aldosterone-excess secretions). Based on these findings, we could select optimal treatment for each case. Therefore, AVS is useful to obtain a definitive diagnosis and adequate therapy for CS with bilateral adrenal tumors. Moreover, there is no consensus regarding the optimal determination of the laterality of excessive cortisol secretion. Thus, standardized criteria for AVS in CS with bilateral adrenal tumors needed to obtain the optimal determination of the laterality of excessive hormone secretion. In this regard, our cases demonstrated detailed data including CT scans, adrenal scintigraphy, confirmatory tests for primary aldosteronism and pathological findings in addition to AVS. Therefore, our report may be used to formulate standard criteria for AVS in CS with bilateral adrenal tumors in the near future.